X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5486) 5486
Newsletter (1400) 1400
Publication (373) 373
Newspaper Article (74) 74
Book Chapter (67) 67
Book Review (50) 50
Conference Proceeding (22) 22
Dissertation (10) 10
Magazine Article (4) 4
Reference (3) 3
Book / eBook (2) 2
Web Resource (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neuromyelitis optica (4215) 4215
humans (3323) 3323
index medicus (2658) 2658
clinical neurology (2159) 2159
female (2071) 2071
multiple sclerosis (1801) 1801
adult (1567) 1567
male (1543) 1543
research (1537) 1537
neuromyelitis-optica (1500) 1500
multiple-sclerosis (1491) 1491
neurosciences (1439) 1439
middle aged (1295) 1295
magnetic resonance imaging (1122) 1122
aquaporins (1109) 1109
neurology (829) 829
neuromyelitis optica - diagnosis (819) 819
medical research (802) 802
aquaporin 4 - immunology (793) 793
neuromyelitis optica - immunology (793) 793
medicine, experimental (762) 762
neuromyelitis optica - pathology (674) 674
optic neuritis (643) 643
antibodies (630) 630
aquaporin-4 (625) 625
adolescent (611) 611
autoimmunity (607) 607
diagnostic-criteria (595) 595
young adult (586) 586
care and treatment (562) 562
aged (558) 558
diagnosis (547) 547
disease (499) 499
immunology (483) 483
neuromyelitis (471) 471
reports (468) 468
spinal cord - pathology (448) 448
animals (435) 435
diagnosis, differential (426) 426
immunoglobulin g (426) 426
autoantibodies - blood (424) 424
aquaporin 4 (422) 422
neuromyelitis optica - complications (410) 410
retrospective studies (408) 408
child (407) 407
neuromyelitis optica - drug therapy (404) 404
analysis (394) 394
autoantibodies (385) 385
brain - pathology (348) 348
myelitis (347) 347
mri (345) 345
neuromyelitis optica - blood (344) 344
marker (336) 336
multiple sclerosis - diagnosis (333) 333
nmo (320) 320
brain (319) 319
lesions (310) 310
neuromyelitis optica spectrum disorder (309) 309
demyelination (308) 308
transverse myelitis (302) 302
abridged index medicus (300) 300
multiple sclerosis - pathology (299) 299
spinal cord (296) 296
viral antibodies (295) 295
recurrence (288) 288
ophthalmology (284) 284
patients (283) 283
neuromyelitis optica - physiopathology (280) 280
autoantibodies - immunology (274) 274
central nervous system (268) 268
nervous system diseases (263) 263
pathogenesis (260) 260
rituximab (259) 259
medicine & public health (257) 257
prognosis (256) 256
nmo-igg (249) 249
neuromyelitis optica spectrum disorders (240) 240
neuromyelitis optica - therapy (239) 239
acute disseminated encephalomyelitis (236) 236
health aspects (236) 236
multiple sclerosis - immunology (235) 235
treatment outcome (235) 235
neuritis (234) 234
autoimmune diseases (228) 228
spectrum (222) 222
central-nervous-system (220) 220
immunoglobulins (220) 220
risk factors (220) 220
psychiatry (218) 218
article (203) 203
inflammation (203) 203
cerebrospinal-fluid (199) 199
nervous system (196) 196
anti-aquaporin-4 antibody (195) 195
follow-up studies (191) 191
immunoglobulin g - blood (191) 191
neuromyelitis optica - epidemiology (191) 191
medicine, general & internal (181) 181
disease progression (180) 180
pathology (180) 180
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6306) 6306
Japanese (164) 164
French (162) 162
Spanish (104) 104
German (95) 95
Chinese (54) 54
Portuguese (26) 26
Korean (22) 22
Czech (14) 14
Russian (14) 14
Hungarian (9) 9
Polish (9) 9
Turkish (9) 9
Italian (7) 7
Danish (5) 5
Dutch (3) 3
Romanian (3) 3
Slovak (2) 2
Bosnian (1) 1
Croatian (1) 1
Finnish (1) 1
Greek (1) 1
Hebrew (1) 1
Norwegian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 279
Background: Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) have been suggested to play a role in a subset of patients with neuromyelitis optica... 
Multiple sclerosis | Autoantibodies | Antibody index | Optic neuritis | Neuromyelitis optica antibodies (NMO-IgG) | Cerebrospinal fluid | Aquaporin-4 antibodies (AQP4-IgG) | Cell-based assays | Transverse Myelitis | Devic's syndrome | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Neuromyelitis optica (NMO) | Neuromyelitis optica spectrum disorders (NMOSD) | Longitudinally extensive transverse myelitis (LETM) | MEDUSA-HEAD ATAXIA | NEUROMYELITIS-OPTICA PHENOTYPE | SPECTRUM DISORDERS | IMMUNOLOGY | AQUAPORIN-4 ANTIBODIES | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | PURKINJE-CELL ANTIBODIES | EXPANDING SPECTRUM | NEUROSCIENCES | DIAGNOSTIC-CRITERIA | CEREBROSPINAL-FLUID ANALYSIS | Myelin-Oligodendrocyte Glycoprotein - immunology | Severity of Illness Index | Myelin-Oligodendrocyte Glycoprotein - genetics | Aquaporin 4 - immunology | Autoantibodies - blood | Humans | Neuromyelitis Optica - physiopathology | Male | Neuromyelitis Optica - blood | Neuromyelitis Optica - immunology | Autoantibodies - cerebrospinal fluid | Transfection | Myelitis - immunology | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Aquaporin 4 - genetics | Adult | Female | Immunoglobulin G | Physiological aspects | Development and progression | Genetic aspects | Neuromyelitis optica | Glycoproteins | Research
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 280
Background: A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has been shown to be seropositive for myelin oligodendrocyte glycoprotein... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Therapy | Multiple sclerosis | Natalizumab | Optic neuritis | Vaccination | Electrophysiology | Infections | Longitudinally extensive transverse myelitis | Cerebrospinal fluid | Ofatumumab | Transverse myelitis | McDonald criteria | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Evoked potentials | Methotrexate | Glatiramer acetate | Autoantibodies | Rituximab | Oligoclonal bands | Pregnancy | Treatment | Magnetic resonance imaging | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Outcome | Interferon beta | Wingerchuk criteria 2006 and 2015 | IPND criteria | Neuromyelitis optica spectrum disorders (NMOSD) | Azathioprine | Barkhof criteria | Methotrexate Azathioprine | MEDUSA-HEAD ATAXIA | ANTIDIURETIC-HORMONE SECRETION | IMMUNOLOGY | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | EXTENSIVE TRANSVERSE MYELITIS | PURKINJE-CELL ANTIBODIES | SPINAL-CORD BIOPSY | POSITIVE NEUROMYELITIS-OPTICA | PREGNANCY-RELATED RELAPSE | NEUROSCIENCES | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Myelin-Oligodendrocyte Glycoprotein - genetics | Brain - diagnostic imaging | Age Distribution | Neuromyelitis Optica - therapy | Humans | Middle Aged | Cardiolipins - immunology | Male | Young Adult | Vaccination - methods | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Child | Optic Nerve - diagnostic imaging | Aquaporin 4 - immunology | Treatment Outcome | Neuromyelitis Optica - diagnostic imaging | Autoantibodies - cerebrospinal fluid | Adolescent | Sex Factors | Aged | Neuromyelitis Optica - epidemiology | Cohort Studies | Vision Disorders - etiology | Measurement | Care and treatment | Physiological aspects | Development and progression | Neuromyelitis optica | Diagnosis | Research
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 11/2017, Volume 23, Issue 13, pp. 1748 - 1756
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 11/2016, Volume 13, Issue 1, p. 281
Background: Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Myelitis | Myelin oligodendrocyte glycoprotein (MOG) antibodies | Respiratory insufficiency | Optic neuritis | Cerebellitis | Intractable nausea and vomiting | MOG-IgG | Rhombencephalitis | Facial nerve palsy | Hearing loss | Diplopia Internuclear ophthalmoplegia (INO) | Ataxia | Neuromyelitis optica spectrum disorders (NMOSD) | Brainstem encephalitis | Longitudinally extensive transverse myelitis (LETM) | IMMUNOLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | ACUTE DISSEMINATED ENCEPHALOMYELITIS | EXTENSIVE TRANSVERSE MYELITIS | AQUAPORIN-4 ANTIBODY | INTERFERON-BETA | CLINICAL-COURSE | NEUROSCIENCES | LESIONS | OPTICA SPECTRUM DISORDERS | NEUROMYELITIS-OPTICA | DIAGNOSTIC-CRITERIA | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuromyelitis Optica - drug therapy | Age Factors | Immunoglobulin G - blood | Encephalitis - diagnostic imaging | Humans | Middle Aged | Male | Neuromyelitis Optica - immunology | Interferon-beta - therapeutic use | Young Adult | Rituximab - therapeutic use | Myelitis - immunology | Adult | Female | Disability Evaluation | Brain Stem - diagnostic imaging | Myelitis - blood | Myelitis - pathology | Encephalitis - immunology | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Blood-Brain Barrier - pathology | Magnetic Resonance Imaging | Adolescent | Brain Stem - physiopathology | Encephalitis - blood | Cohort Studies | Prevention | Immunoglobulin G | Immunotherapy | Influence | Brain damage | Research | Health aspects | Myelin proteins | Risk factors
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 07/2017, Volume 89, Issue 3, pp. 269 - 278
Journal Article
Neurology, ISSN 0028-3878, 08/2017, Volume 89, Issue 9, pp. 900 - 908
Journal Article